|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||41.96 - 42.79|
|52 Week Range||26.92 - 45.92|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||37.72|
|Earnings Date||Jul 20, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 30, 2020|
|1y Target Est||38.47|
The maker of pricey lithography systems for major chip makers ran into demand problems early in the outbreak. But now it’s looking to a post-Covid world of cloud computing, videogaming, and driverless cars.
Philips (PHG) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
July 9, 2020 First and only clinically-validated mask selection, sizing and fitting solution that helps providers fit patients with the right mask from the.
July 9, 2020 Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has earned a place on Boston Consulting Group’s (BCG) "The Most Innovative Companies 2020" ranking of the top 50 most innovative companies worldwide, moving up 6 spots from 2019. In its new 2020 position at number 23, Philips also ranks as the most innovative medtech company and is one of only 162 companies to have ever appeared on the list in its 14 years of publication.
Koninklijke Philips (PHG) said it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its monitors and displays to be used for Covid-19 patients in U.S. hospitals.The technology company said the emergency use authorization is for its IntelliVue Patient Monitors MX750 and MX850 as well as its IntelliVue Active Displays AD75 and AD85. The patient monitoring products help to collate infection-control protocols and remotely provide patient information for caregivers, which are much needed when caring for hospitalized COVID-19 patients, the company said.The FDA authorization enables the company to start delivering the new remote patient monitoring products to U.S. hospitals. Patient monitors, which enable clinicians to remotely monitor a patient’s condition can help hospitals minimize staff exposure to the virus that causes COVID-19.“As the world continues to battle against COVID-19, we’re committed to ramping up production of all critical solutions that can help in this time of crisis,” said Peter Ziese, General Manager, Monitoring and Analytics at Philips. “This FDA EUA for our MX750 and MX850 monitors and IntelliVue AD75 and AD85 Active Displays allows us to do that for these remote patient monitoring solutions, which are of vital need in the intensive care unit.”Furthermore, Philips said it is significantly increasing its patient monitor production to address the demand for more intensive care unit (ICU) capacity.Shares in Philips, which slumped to a multi-year low in March have since been on a steady gaining streak, advancing some 44%. The stock was little changed at $45.72 in midday U.S. trading.Last month, Kepler Capital analyst David Cerdan maintained a Hold rating on the stock with a $37.85 price target. Meanwhile, DZ Bank analyst Elmar Kraus upgraded Philips to Buy from Hold with a $41.19 price target.Following the stock’s recent rally, the $39.52 average price target implies 14% downside potential in the shares in the coming 12 months. (See Philips stock analysis on TipRanks).Related News: Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients Novavax Seeks To Make 1 Billion Covid-19 Vaccine Doses Eli Lilly Starts Dosing Patients In World’s First Covid-19 Antibody Trial More recent articles from Smarter Analyst: * Sanofi Seeks Growth Strategy For Dupixent Drug To Meet €10B Peak Sales Target * Beyond Meat Boosts Europe Presence As Global Expansion Continues * Tesla Said To Have Won Chinese Nod To Build Model 3 Cars With LFP Batteries * Sorrento Soars 17% In Pre-Market On Covid-19 Test Application
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company once again has earned a place on the Forbes "Global 2000: The World’s Largest Public Companies" list, moving up 46 spots from 2019. In its new 2020 position, the company now also ranks as one of the top ten global public healthcare companies. The annual list, which has been released for the past 18 years, features a ranking of the biggest, most powerful and most valuable companies in the world. Philips ranked 385 out of the 2,000 publicly traded companies on the full list.
Philips is integrating additional Masimo monitoring technologies into select Philips multi-parameter patient monitors.
Dutch electronics giant Philips signed a contract with the European Commission to supply medical ventilators to EU hospitals, the company and EU officials said, in a deal that comes as most EU countries reached the peak of the COVID-19 outbreak. Other companies have signed similar contracts with the European Union as part of a joint procurement scheme the Commission launched in March on behalf of 25 EU states.
U.S. weapons makers have teamed up with medical device companies to increase the supply of ventilators that can be used to combat the coronavirus pandemic, people working on the project said. The two groups do not regularly partner on projects, but when a defense industry consultant with an engineering background realized weapons makers could help solve supply-chain problems within the U.S. ventilator industry, the creation of Vent Connect was set in motion and is set to be announced on Monday, the people said. The idea gathered momentum when industry associations like the Aerospace Industries Association, which represents plane makers and defense contractors including Lockheed Martin Corp and General Dynamics Corp, teamed up with AdvaMed, the Advanced Medical Technology Association, whose members include vent manufacturers.
Moody's Investors Service, ("Moody's") has today assigned a Baa3 rating to Signify N.V. (Signify) proposed issue of Euro-denominated floating and fixed rate senior unsecured notes. Moody's assesses Signify's liquidity profile as good.
The Trump administration, under pressure to do more to ramp up coronavirus testing in order to safely reopen the battered U.S. economy, is highlighting this week a $2.9 billion program to build 187,000 ventilators this year. The administration's ventilator surge is accelerating as medical experts are forecasting the need for the devices - used to help severely ill COVID-19 patients breathe - will fall. Many of the ventilators will now be sent to other countries in need, the administration says.
European stocks started higher on Monday, continuing the rally from coronavirus lows, on data showing the disease’s spread is slowing.
European stocks opened higher on Monday, gaining about 0.4% in early action. The Stoxx Europe 600 has climbed 7.9% over the last two weeks on optimism over the slowing spread of the coronavirus and the gradual reopening of economies. Vivendi and Philips each rose after reporting first-quarter results. U.S. stock futures slipped after the powerful Wall Street rally on Friday.
European shares edged higher on Monday as coronavirus deaths slowed in hotspots Italy and Spain, but the mood remained cautious with companies preparing to report their worst quarterly earnings since the 2008 financial crisis. The pan-European STOXX 600 index was up 0.4% at 0701 GMT, after ending Friday with its biggest two-week percentage gain since 2015.
Sales and profit margins at Dutch health technology company Philips <PHG.AS> could still rise this year, provided the coronavirus pandemic eases in the coming months and hospitals are able to restart elective operations, it said on Monday. The optimism contrasts with the gloom engulfing much of the corporate world as lockdowns to contain the pandemic hammer business, and partly reflects strong orders for Philips' medical ventilators used for treating the sickest coronavirus patients. The electric toothbrush to hospital scanners maker scrapped its previous 2020 forecasts for 4-6% comparable sales growth and a 100 basis point improvement in operating profit margin, as the disruption from the health crisis hit first-quarter results and it warned the second quarter could be even worse.
Moody's Investors Service, ("Moody's") today downgraded the corporate family rating of Bright Bidco B.V. (BBBV, Lumileds) to Caa3 from Caa1 and the probability of default rating to Caa3-PD from Caa1-PD. Moody's also downgraded to Caa3 from Caa1 the senior secured term loan B (TLB) and the $200 million senior secured revolving credit facility, both with BBBV as the borrower. Moody's downgraded the ratings to Caa3 following extremely challenging conditions in BBBV's core end-markets automotive and consumer LED, which are additionally burdened by the impact from the covid 19 outbreak.